Skip to main content
PMC home page
Annals of the Rheumatic Diseases logoLink to Annals of the Rheumatic Diseases
. 1978 Oct;37(5):432–435. doi: 10.1136/ard.37.5.432

On the relationship between gastrin, gastric secretion, and adjuvant arthritis in rats.

P J Rooney, W C Dick, R C Imrie, D Turner, K D Buchanan, J Ardill
PMCID: PMC1000271  PMID: 718275

Abstract

The elevation of plasma immunoreactive gastrin known to occur during the induction of adjuvant-induced arthritis (Rooney et al., 1973) has been shown to be maximal at 7 days after injection. Gastrin administered exogenously accelerated and exacerbated the inflammatory joint disease. Some evidence has been presented that the endogenous immunoreactive gastrin had biological activity in terms of gastric acid secretion.

Full text

PDF
432

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Currey H. L., Ziff M. Suppression of experimentally induced polyarthritis in the rat by heterologous anti-lymphocyte serum. Lancet. 1966 Oct 22;2(7469):889–891. doi: 10.1016/s0140-6736(66)91984-2. [DOI] [PubMed] [Google Scholar]
  2. Ganguli P. C., Cullen D. R., Irvine W. J. Radioimmunoassay of plasmagastrin in pernicious anaemia, achlorhydria without pernicious anaemia, hypochlorhydria, and in controls. Lancet. 1971 Jan 23;1(7691):155–158. doi: 10.1016/s0140-6736(71)91932-5. [DOI] [PubMed] [Google Scholar]
  3. Greaves M. W., Sondergaard J., McDonald-Gibson W. Recovery of prostaglandins in human cutaneous inflammation. Br Med J. 1971 May 1;2(5756):258–260. doi: 10.1136/bmj.2.5756.258. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. HUNTER W. M., GREENWOOD F. C. Preparation of iodine-131 labelled human growth hormone of high specific activity. Nature. 1962 May 5;194:495–496. doi: 10.1038/194495a0. [DOI] [PubMed] [Google Scholar]
  5. Karim S. M., Carter D. C., Bhana D., Ganesan P. A. Effect of orally administered prostaglandin E 2 and its 15-methyl analogues on gastric secretion. Br Med J. 1973 Jan 20;1(5846):143–146. doi: 10.1136/bmj.1.5846.143. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. McQueen E. G. Anti-inflammatory drug mechanisms. Drugs. 1973;6(2):104–117. doi: 10.2165/00003495-197306020-00004. [DOI] [PubMed] [Google Scholar]
  7. Rooney P. J., Dick W. C., Imrie R. C., Buchanan K. D. Animal model to study the relationship between immunoreactive gastrin and inflammatory arthritis. Nature. 1973 Dec 21;246(5434):497–498. doi: 10.1038/246497a0. [DOI] [PubMed] [Google Scholar]
  8. Rooney P. J., Kennedy A. C., Gray G. H., Sturrock R. D., Buchanan K. D., Dick W. C. Serum immunoreactive gastrin in rheumatoid arthritis. Further observations on its identity, clinical specificity, and relationship to gastric function. Ann Rheum Dis. 1976 Jun;35(3):246–250. doi: 10.1136/ard.35.3.246. [DOI] [PMC free article] [PubMed] [Google Scholar]
  9. Ward P. A. The inflammatory mediators. Ann N Y Acad Sci. 1974;221:290–298. doi: 10.1111/j.1749-6632.1974.tb28228.x. [DOI] [PubMed] [Google Scholar]
  10. Yalow R. S., Berson S. A. Radioimmunoassay of gastrin. Gastroenterology. 1970 Jan;58(1):1–14. [PubMed] [Google Scholar]

Articles from Annals of the Rheumatic Diseases are provided here courtesy of BMJ Publishing Group

RESOURCES